| Q33785593 | A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo |
| Q28271040 | Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells |
| Q30868385 | Alu-associated interstitial deletions and chromosomal re-arrangement in 2 human multidrug-resistant cell lines |
| Q43719596 | Cathepsin B-like cysteine proteases and Caenorhabditis elegans homologues dominate gene products expressed in adult Haemonchus contortus intestine |
| Q33422583 | Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans |
| Q40115005 | Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells |
| Q95839654 | Decreased expression of FBXW7 by ERK1/2 activation in drug-resistant cancer cells confers transcriptional activation of MDR1 by suppression of ubiquitin degradation of HSF1 |
| Q89511017 | Dephosphorylation of YB-1 is Required for Nuclear Localisation During G2 Phase of the Cell Cycle |
| Q28200031 | Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression |
| Q34356546 | Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines |
| Q42491601 | Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer |
| Q36458742 | Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy |
| Q47102526 | Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance |
| Q36546044 | Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity. |
| Q34106549 | Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport |
| Q59607864 | Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport |
| Q34335257 | Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1 |
| Q24803603 | Gene trapping identifies transiently induced survival genes during programmed cell death |
| Q38295189 | Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins |
| Q39955187 | Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells |
| Q33879051 | Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes |
| Q28579441 | Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling |
| Q35749503 | Immunological response as a source to variability in drug metabolism and transport |
| Q33707662 | Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation |
| Q34928974 | Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells |
| Q89454128 | Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells |
| Q38358712 | NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells |
| Q24298410 | NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines |
| Q53942408 | Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma. |
| Q47918094 | Nuclear localization of Y-box factor YB1 requires wild-type p53 |
| Q37049619 | Nuclease sensitive element binding protein 1 gene disruption results in early embryonic lethality |
| Q64068862 | Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer |
| Q43572871 | Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy |
| Q58581010 | Oxidative Stress Causes Enhanced Secretion of YB-1 Protein that Restrains Proliferation of Receiving Cells |
| Q33939605 | Prognostic association of YB-1 expression in breast cancers: a matter of antibody. |
| Q24294624 | Proteasomal degradation of the multifunctional regulator YB-1 is mediated by an F-Box protein induced during programmed cell death |
| Q28191900 | Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells |
| Q34282236 | Recognition of cisplatin adducts by cellular proteins |
| Q38310414 | Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors |
| Q24315064 | Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. |
| Q40734751 | Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation |
| Q36436693 | Some p53-binding proteins that can function as arbiters of life and death. |
| Q48224893 | Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers |
| Q38302263 | Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. |
| Q33557244 | Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters |
| Q34265716 | Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models |
| Q27006654 | Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y? |
| Q35112113 | The basic and clinical implications of ABC transporters, Y‐box‐binding protein‐1 (YB‐1) and angiogenesis‐related factors in human malignancies |
| Q35195895 | The expression level and prognostic value of Y-box binding protein-1 in rectal cancer |
| Q38357771 | The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage |
| Q37525847 | The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress |
| Q30175138 | The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression |
| Q41998043 | The tumor-associated YB-1 protein: new player in the circadian control of cell proliferation |
| Q40730326 | Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells |
| Q38541481 | Transcription factors that interact with p53 and Mdm2 |
| Q35567283 | Transcriptional regulation of ABC drug transporters |
| Q37323510 | Transcriptional regulation of MDR genes |
| Q37918838 | Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease |
| Q36350264 | Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway |
| Q39922380 | Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer. |
| Q36197071 | Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells |
| Q35021157 | Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction |
| Q28578217 | Y-box factor YB1 controls p53 apoptotic function |
| Q31150111 | Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells |
| Q39682899 | YB-1 binds to GluR2 mRNA and CaM1 mRNA in the brain and regulates their translational levels in an activity-dependent manner |
| Q42475185 | YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene |
| Q36791090 | YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression |
| Q40600190 | YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins |
| Q30635379 | YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1. |
| Q39582510 | YBX1 expression and function in early hematopoiesis and leukemic cells. |
| Q36311301 | YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro. |
| Q36228025 | mRNA and DNA selection via protein multimerization: YB-1 as a case study. |